Skip to main content
. 2022 Aug 25;23(17):9653. doi: 10.3390/ijms23179653

Table 3.

Differential expression of genes relevant to depression, in depression, after established antidepressant treatment, and following JB-1 treatment in mice. The up and down arrows represent the direction of change in pathway expression in our findings and in literature.

Gene SGK1 GPM6B NCDN CLSTN1
Change in Depression ↓ in hippocampus of rats [56] ↓ in the hippocampus of humans [60] ↓ in CNS of mice [80] ↓ in blood of humans [66], ↑ in hippocampus of rats and mice [67]
Change in Depression Treatment ↑ mRNA in hippocampus and prefrontal cortex of rats following icariin or baicalin treatment [81,82] N/A ↓ in hippocampus after ketamine treatment in rats [83] N/A
Change Following JB-1 ↑ mRNA in hippocampus of mice (4.5 × 10−2) ↑ mRNA in blood of mice (7.6 × 10−4) ↑ mRNA in blood of mice (8.5 × 10−3) ↑ mRNA in blood of mice (1.6 × 10−2)